On November 21, 2022, Curevo, Inc. closed the transaction. The company has issued 8,382,933 shares for gross proceeds of $22,000,002 in the transaction. The transaction included participation from seven investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.94 USD | +0.89% | -0.27% | +9.25% |
May. 09 | North American Income replaces investment manager | AN |
May. 07 | Energy Flat as Traders Await Ceasefire, OPEC Negotiations - Energy Roundup | DJ |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
114,400 KRW | -0.17% | +0.79% | 955M | ||
32.94 USD | +0.89% | -0.27% | 5.28B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.25% | 5.28B | |
-2.64% | 117B | |
+3.91% | 95.8B | |
+13.11% | 68.56B | |
+17.80% | 62.47B | |
+11.14% | 43.26B | |
+13.72% | 42.9B | |
+20.57% | 35.33B | |
+4.62% | 25.16B | |
-1.68% | 22.94B |
- Stock Market
- Equities
- JHG Stock
- News Janus Henderson Group plc
- Curevo, Inc. announced that it has received $22.000002 million in funding from Janus Henderson Group plc, RA Capital Management, L.P., Adjuvant Capital, LP, GC Biopharma Corp. and other investors